The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, however its legacy within the broader industry now presents questions about future yields . Alternative versions are eroding patent protection , prompting concerns that investing in companies heavily reliant to Viagra's once-dominant standing could be a specul